DE69306119T2 - Kügelchen bestehend aus einem mit antimikolischem wirkstoff und polymer überzogenen kern - Google Patents

Kügelchen bestehend aus einem mit antimikolischem wirkstoff und polymer überzogenen kern

Info

Publication number
DE69306119T2
DE69306119T2 DE69306119T DE69306119T DE69306119T2 DE 69306119 T2 DE69306119 T2 DE 69306119T2 DE 69306119 T DE69306119 T DE 69306119T DE 69306119 T DE69306119 T DE 69306119T DE 69306119 T2 DE69306119 T2 DE 69306119T2
Authority
DE
Germany
Prior art keywords
antimicolic
polymer
active substance
core coated
balls constructed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69306119T
Other languages
English (en)
Other versions
DE69306119D1 (de
Inventor
Paul M V Gilis
Conde Valentin F V De
Roger P G Vandecruys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69306119(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE69306119D1 publication Critical patent/DE69306119D1/de
Application granted granted Critical
Publication of DE69306119T2 publication Critical patent/DE69306119T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
DE69306119T 1992-09-03 1993-08-27 Kügelchen bestehend aus einem mit antimikolischem wirkstoff und polymer überzogenen kern Expired - Lifetime DE69306119T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92202664 1992-09-03
PCT/EP1993/002327 WO1994005263A1 (en) 1992-09-03 1993-08-27 Beads having a core coated with an antifungal and a polymer

Publications (2)

Publication Number Publication Date
DE69306119D1 DE69306119D1 (de) 1997-01-02
DE69306119T2 true DE69306119T2 (de) 1997-03-13

Family

ID=8210890

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69306119T Expired - Lifetime DE69306119T2 (de) 1992-09-03 1993-08-27 Kügelchen bestehend aus einem mit antimikolischem wirkstoff und polymer überzogenen kern

Country Status (33)

Country Link
US (1) US5633015A (de)
EP (1) EP0658103B1 (de)
JP (1) JP2865869B2 (de)
KR (1) KR0151893B1 (de)
CN (1) CN1034714C (de)
AP (1) AP444A (de)
AT (1) ATE145327T1 (de)
AU (1) AU665867B2 (de)
CA (1) CA2142848C (de)
CY (1) CY2105B1 (de)
CZ (1) CZ283403B6 (de)
DE (1) DE69306119T2 (de)
DK (1) DK0658103T3 (de)
ES (1) ES2097536T3 (de)
FI (1) FI112437B (de)
GR (1) GR3022198T3 (de)
HK (1) HK1006000A1 (de)
HR (1) HRP931158B1 (de)
HU (1) HU220614B1 (de)
IL (1) IL106871A (de)
MX (1) MX9305438A (de)
MY (1) MY109369A (de)
NO (1) NO307953B1 (de)
NZ (1) NZ255379A (de)
OA (1) OA10130A (de)
PH (1) PH30929A (de)
PL (2) PL174178B1 (de)
RU (1) RU2125445C1 (de)
SG (1) SG48801A1 (de)
SI (1) SI9300461B (de)
TW (1) TW376322B (de)
WO (1) WO1994005263A1 (de)
ZA (1) ZA936493B (de)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
TR199701323T1 (xx) 1995-05-09 1998-02-21 Colorcon Limited Farmas�tik alttabakalar�n elektrostatik olarak kaplanmas� i�in toz kaplama kompozisyonu.
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
US5750147A (en) * 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
CA2240161C (en) 1996-05-20 2005-05-24 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
CN1228693A (zh) * 1996-06-28 1999-09-15 先灵公司 含有三唑类抗真菌化合物的口服组合物
US5846971A (en) * 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
ID21477A (id) * 1997-03-26 1999-06-17 Janssen Pharmaceutica Nv Pelet-pelet yang mempunyai inti yang dilapisi dengan suatu anti jamur dan suatu polimer
KR19990001564A (ko) 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
JP3696087B2 (ja) * 1997-12-31 2005-09-14 チョンワエ ファーマ コーポレーション イトラコナゾール（ｉｔｒａｃｏｎａｚｏｌｅ）経口用製剤及びその製造方法
KR100514330B1 (ko) * 1997-12-31 2006-02-17 주식회사 중외제약 난용성 약물을 함유하는 코팅정
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
EP1104291B1 (de) * 1998-07-17 2005-09-07 Janssen Pharmaceutica N.V. Granulat mit einem fungizid und einem polymer umhüllten kern
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ATE307808T1 (de) 1999-03-24 2005-11-15 Scherer Technologies Inc R P Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
WO2001047492A1 (en) * 1999-12-23 2001-07-05 F H Faulding & Co Limited Improved pharmaceutical compositions for poorly soluble drugs
CN1310999A (zh) * 2000-02-29 2001-09-05 布里斯托尔-迈尔斯斯奎布公司 低剂量艾替开韦制剂及其应用
US6551608B2 (en) * 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US6663897B2 (en) 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
ES2275866T3 (es) 2001-02-14 2007-06-16 Tibotec Pharmaceuticals Ltd. 2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih.
AP1544A (en) 2001-04-09 2006-01-12 Tibotec Pharm Ltd Broadspectrum 2- (substituted-amino) -benzoxazole sulfonamide HIV protease inhibitors.
EA009590B1 (ru) 2001-05-11 2008-02-28 Тиботек Фармасьютикалз Лтд. 2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
KR100438485B1 (ko) * 2001-08-13 2004-07-09 한국디디에스제약 주식회사 아졸류 항진균제의 약제학적 조성물
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
CA2363376A1 (en) * 2001-11-16 2003-05-16 Bernard Charles Sherman Solid pharmaceutical compositions for oral administration comprising itraconazole
JP4578101B2 (ja) 2001-12-21 2010-11-10 テイボテク・フアーマシユーチカルズ・リミテツド 幅広いスペクトルのｈｉｖプロテアーゼ阻害剤である複素環置換フェニル含有スルホンアミド
US20050025791A1 (en) * 2002-06-21 2005-02-03 Julius Remenar Pharmaceutical compositions with improved dissolution
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7446107B2 (en) * 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
AU2003213719A1 (en) 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
ATE371652T1 (de) 2002-05-17 2007-09-15 Tibotec Pharm Ltd Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
EP1511490A4 (de) * 2002-05-31 2009-03-11 Transform Pharmaceuticals Inc Neue kristalline conazol-formen und verwandte prozesse, pharmazeutische zusammensetzungen und verfahren
JP2005533846A (ja) * 2002-07-22 2005-11-10 ナノハイブリッド カンパニー リミテッド イトラコナゾール、シクロスポリン、またはカルベジロールと層状型珪酸塩との混成体及びその製造方法
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
JP4681296B2 (ja) 2002-08-14 2011-05-11 テイボテク・フアーマシユーチカルズ・リミテツド スペクトルの広い置換オキシインドールスルホンアミドｈｉｖプロテアーゼ阻害剤
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
JP5271475B2 (ja) 2002-11-26 2013-08-21 ザ ユニヴァーシティー オヴ シカゴ 微生物媒介上皮疾患の予防及び治療のための材料並びに方法
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
SI1438960T2 (sl) * 2003-01-14 2013-04-30 Cimex Pharma Ag Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
AU2004269930B2 (en) 2003-09-11 2011-08-04 Tibotec Pharmaceuticals Ltd. Entry inhibitors of the HIV virus
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
CA2558027A1 (en) * 2004-03-03 2005-09-15 Spherics, Inc. Polymeric drug delivery system for hydrophobic drugs
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
JP5073480B2 (ja) 2004-05-07 2012-11-14 セコイア、ファーマシューティカルズ、インコーポレイテッド 耐性防止レトロウイルスプロテアーゼ阻害薬
EP1758911A1 (de) 2004-05-17 2007-03-07 Tibotec Pharmaceuticals Ltd. 1-heterocyclyl-1,5-dihydropyrido[3,2-b]indol-2-one
MXPA06013315A (es) 2004-05-17 2007-02-02 Tibotec Pharm Ltd 1,5-dihidro-pirido[3,2-b]indol-2-onas 4-sustituidas.
ATE481403T1 (de) 2004-05-17 2010-10-15 Tibotec Pharm Ltd Substituierte 1-phenyl-1,5-dihydro-pyridoä3,2- büindol-2-on-derivate verwendbar als pharmazeutische antiinfektiva
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
US20060045822A1 (en) * 2004-09-01 2006-03-02 Board Of Regents, The University Of Texas System Plasma polymerization for encapsulating particles
US20100297248A1 (en) * 2004-09-01 2010-11-25 Board Of Regents, The University Of Texas System Encapsulated particles for amorphous stability enhancement
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
TW200710091A (en) 2005-04-11 2007-03-16 Tibotec Pharm Ltd (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
EP1912682A4 (de) * 2005-07-21 2008-08-20 Nomir Medical Technologies Inc Nahinfrarot-mikrobeneliminationslasersystem (nimels)
US20070148240A1 (en) * 2005-12-23 2007-06-28 Fang-Yu Lee Oral formulation containing itraconazole and methods for manufacturing and using the same
CN101415708A (zh) 2006-04-03 2009-04-22 泰博特克药品有限公司 抑制HIV的3,4-二氢-咪唑并[4,5-b]吡啶-5-酮
CN101091725A (zh) * 2006-06-23 2007-12-26 天津天士力制药股份有限公司 一种中药颗粒及其制备方法
WO2008110534A1 (en) * 2007-03-13 2008-09-18 Sandoz Ag Pharmaceutical compositions of poorly soluble drugs
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US7314641B1 (en) 2007-04-18 2008-01-01 Everest Pharm. Industrial Co., Ltd. High-bioavailability particle coated with fungicide and polymer
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
BRPI0819883A2 (pt) 2007-11-28 2017-05-23 Sequoia Pharmaceuticals Inc composições e métodos para inibir citocromo p450 2d6
CA2716348C (en) 2008-02-21 2017-04-04 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome p450
US8088451B2 (en) 2008-03-13 2012-01-03 Board Of Regents, The University Of Texas System Covalently functionalized particles for synthesis of new composite materials
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
SG174658A1 (en) * 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
WO2011146078A1 (en) * 2010-05-21 2011-11-24 Board Of Regents, The University Of Texas System Encapsulated particles for enteric release
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
MX337364B (es) * 2010-12-16 2016-02-29 Borje S Andersson Formulaciones farmaceuticas de azol para la administracion parenteral y metodos para preparar y usar las mismas como tratamiento de las enfermedades sensibles a los compuestos de azol.
US8940763B2 (en) 2011-05-10 2015-01-27 Theravida, Inc. Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
CA2876909C (en) 2012-06-21 2022-08-16 Mayne Pharma International Pty. Ltd. Itraconazole compositions and dosage forms, and methods of using the same
CN103948911B (zh) * 2014-04-23 2016-04-20 深圳市健元医药科技有限公司 一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
RU2718906C2 (ru) 2016-01-20 2020-04-15 Теравида, Инк. Способы и композиции для лечения гипергидроза
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
US5049374A (en) * 1989-11-28 1991-09-17 Dansereau Richard J Oral (coated bead) dosage form for sodium iodide I-131
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions

Also Published As

Publication number Publication date
ZA936493B (en) 1995-03-02
CA2142848A1 (en) 1994-03-17
PH30929A (en) 1997-12-23
MX9305438A (es) 1994-03-31
MY109369A (en) 1997-01-31
GR3022198T3 (en) 1997-03-31
CZ54295A3 (en) 1995-09-13
HUT70419A (en) 1995-10-30
HU220614B1 (hu) 2002-03-28
ES2097536T3 (es) 1997-04-01
FI950975A0 (fi) 1995-03-02
JP2865869B2 (ja) 1999-03-08
SI9300461B (en) 2001-12-31
HK1006000A1 (en) 1999-02-05
WO1994005263A1 (en) 1994-03-17
OA10130A (en) 1996-12-18
SI9300461A (en) 1994-03-31
NO307953B1 (no) 2000-06-26
ATE145327T1 (de) 1996-12-15
HU9500642D0 (en) 1995-04-28
US5633015A (en) 1997-05-27
DE69306119D1 (de) 1997-01-02
HRP931158B1 (en) 1999-02-28
TW376322B (en) 1999-12-11
CY2105B1 (en) 2002-04-26
CN1088432A (zh) 1994-06-29
IL106871A0 (en) 1993-12-28
CA2142848C (en) 1999-11-16
HRP931158A2 (en) 1995-06-30
AP444A (en) 1996-01-19
KR0151893B1 (ko) 1998-10-15
SG48801A1 (en) 1998-05-18
CN1034714C (zh) 1997-04-30
PL172676B1 (pl) 1997-11-28
RU2125445C1 (ru) 1999-01-27
IL106871A (en) 1998-02-22
CZ283403B6 (cs) 1998-04-15
PL174178B1 (pl) 1998-06-30
FI112437B (fi) 2003-12-15
PL307791A1 (en) 1995-06-26
DK0658103T3 (da) 1996-12-09
JPH08501092A (ja) 1996-02-06
NZ255379A (en) 1996-06-25
AP9300563A0 (en) 1993-10-31
EP0658103A1 (de) 1995-06-21
NO950829L (no) 1995-05-02
AU665867B2 (en) 1996-01-18
NO950829D0 (no) 1995-03-02
FI950975A (fi) 1995-03-02
AU4954693A (en) 1994-03-29
EP0658103B1 (de) 1996-11-20

Similar Documents

Publication Publication Date Title
DE69306119T2 (de) Kügelchen bestehend aus einem mit antimikolischem wirkstoff und polymer überzogenen kern
DE69815316D1 (de) Tabletten mit einem kern, der mit einem pilzbekämpfungsmittel und einem polymeren beschichtet ist
DE69528204T2 (de) Tabletten enthaltend Amoxicillin und Clavulanate, die mit einem Polymerüberzug versehen sind
ATE303798T1 (de) Granulat mit einem fungizid und einem polymer umhüllten kern
GB2241889B (en) Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
DE69232148D1 (de) Kontinuierliche Querelement-Geräte und Verfahren zu deren Herstellung
FR2683577B1 (fr) Dispositifs et structures modulaires d'amenagements paysagers.
DE59301428D1 (de) Polymerharze und deren Verwendung
DE69529399T2 (de) Gerät mit einem bildschirm mit aktivem und passivem modus
FR2736197B1 (fr) Nanoparticules magnetiques couplees a de l'annexine et leur utilisation
DE69816941D1 (de) Bewegungsdämpfer mit elektrischem verstärker und lithograhieeinrichtung mit einem solchen bewegungsdämpfer
DE69411319T2 (de) Körmige, beschichtete Magnetitteilchen und deren Herstellungsverfahren
ATE36506T1 (de) Fadenspeicher- und liefervorrichtung.
NO941903D0 (no) Fortilsetning for drövtyggere samt forpellet inneholdende samme
DE69112460T2 (de) Mit Kohlenstoff beschichtete inorganische Oxydpartikel und dieselben mit einem Polymerüberzug.
DE59406960D1 (de) Elektrode, bestehend aus einem Eisen-haltigen Kern und einem Blei-haltigem Überzug
ITMI930115A1 (it) Scaffalatore
DE59503969D1 (de) Transport-Gruppier- und Speichervorrichtung
FI933808A0 (fi) Insekticidiskt aktiva peptider
DE69301885D1 (de) Quantenbauelement und dessen Herstellungsverfahren
DE59204616D1 (de) Fadenspeicher- und -liefervorrichtung.
DE59501330D1 (de) Fadenbremsvorrichtung und fadenspeicher- und -liefervorrichtung
DE69221894T2 (de) Verbandprodukt mit kern aus alginat-fasern
BR9301172A (pt) Aerossois dosadores contendo a substancia ativa flezelastina e estruturas afins
DE9403202U1 (de) Magnetische Lagerungseinrichtung mit Hoch-Tc-Supraleitermaterial

Legal Events

Date Code Title Description
8364 No opposition during term of opposition